COR · News · 20260806N
Operating Margin Drivers
Cencora, Inc. · 2026-08-06 · Importance 30 · Surprise 40 · In source text
Adjusted operating income increased 17% year over year in fiscal third quarter 2026. Adjusted gross profit rose 23%, supported by the OneOncology acquisition and a richer specialty-product mix. Strong specialty growth was partly offset by margin pressure from the increasing mix of GLP-1 products and manufacturer list-price reductions.
Key facts
- Adjusted gross profit rose by 23%, according to one report attributing improvement to OneOncology acquisition and richer specialty mix. source
- Simply Wall St reported adjusted operating income growth and attributed margin expansion to OneOncology and a richer specialty mix, noting adjusted operating income increased 17% and adjusted gross profit rose 23%. source
- One outlet reported 'double-digit adjusted operating income growth of 17% and EPS growth of 12%.' source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | positive | realized | — | Adjusted gross profit rose by 23%, according to one report attributing improvement to OneOncology acquisition and richer specialty mix. |